Search Count: 23
All
Selected
 |
Organism: Human coronavirus hku1
Method: X-RAY DIFFRACTION Resolution:2.21 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHF |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHJ, PO4 |
 |
Organism: Human coronavirus 229e
Method: X-RAY DIFFRACTION Resolution:1.32 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHJ, 12P |
 |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHJ |
 |
Organism: Infectious bronchitis virus
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2026-05-06 Classification: VIRAL PROTEIN Ligands: A1CHJ |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.83 Å Release Date: 2026-02-11 Classification: VIRAL PROTEIN Ligands: A1CHF, PO4 |
 |
Organism: Human coronavirus 229e
Method: X-RAY DIFFRACTION Resolution:1.41 Å Release Date: 2026-02-11 Classification: VIRAL PROTEIN Ligands: A1CHF, 12P |
 |
Organism: Middle east respiratory syndrome-related coronavirus
Method: X-RAY DIFFRACTION Resolution:2.28 Å Release Date: 2026-02-11 Classification: VIRAL PROTEIN Ligands: A1CHF |
 |
Organism: Infectious bronchitis virus
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2026-02-11 Classification: VIRAL PROTEIN Ligands: A1CHF |
 |
Organism: Human coronavirus oc43
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2026-02-11 Classification: VIRAL PROTEIN Ligands: A1CHF |
 |
Organism: Sars-cov-2 pseudovirus
Method: X-RAY DIFFRACTION Resolution:2.18 Å Release Date: 2024-10-23 Classification: VIRAL PROTEIN Ligands: ZN, SAH, EDO, IMD, YDT, CL |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.44 Å Release Date: 2024-03-06 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: I70, PO4 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2024-03-06 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: X83 |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.44 Å Release Date: 2024-03-06 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: X8F |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2024-03-06 Classification: VIRAL PROTEIN, HYDROLASE/INHIBITOR Ligands: XKQ, EDO |
 |
Crystal Structure Of Potent Neutralizing Antibody 10-40 In Complex With Bat Wiv1 Receptor-Binding Domain
Organism: Bat sars-like coronavirus wiv1, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.11 Å Release Date: 2022-05-04 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
Crystallographic Structure Of Neutralizing Antibody 10-40 In Complex With Sars-Cov-2 Spike Receptor Binding Domain
Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2022-04-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
Crystal Structure Of Neutralizing Antibody 10-28 In Complex With Sars-Cov-2 Spike Receptor Binding Domain (Rbd)
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:3.20 Å Release Date: 2022-04-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM |
 |
Crystal Structure Of Potent Neutralizing Antibody 10-40 In Complex With Sarbecovirus Bat Shc014 Receptor-Binding Domain
Organism: Bat sars-like coronavirus rsshc014, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.24 Å Release Date: 2022-04-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
 |
Crystal Structure Of Potent Neutralizing Antibody 10-40 In Complex With Sarbecovirus Bat Ratg13 Receptor-Binding Domain
Organism: Bat coronavirus ratg13, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2022-04-27 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |